Evidence map›Paper›PMID 38010801›Full record

ArticlemAbs

BERT2DAb: a pre-trained model for antibody representation based on amino acid sequences and 2D-structure.

Xiaowei Luo, Fan Tong, Wenbin Zhao, Xiangwen Zheng, Jiangyu Li, Jing Li, Dongsheng Zhao

Abstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. A comprehensive overview of recent advances in generative models for antibodies.Computational and structural biotechnology journal · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaowei LuoInformation Center, Academy of Military Medical Sciences, Beijing, China.
Fan TongInformation Center, Academy of Military Medical Sciences, Beijing, China.
Wenbin ZhaoInformation Center, Academy of Military Medical Sciences, Beijing, China.
Xiangwen ZhengInformation Center, Academy of Military Medical Sciences, Beijing, China.
Jiangyu LiInformation Center, Academy of Military Medical Sciences, Beijing, China.
Jing LiState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Dongsheng ZhaoInformation Center, Academy of Military Medical Sciences, Beijing, China.ORCID 0000-0003-2616-8891

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prior research has generated a vast amount of antibody sequences, which has allowed the pre-training of language models on amino acid sequences to improve the efficiency of antibody screening and optimization. However, compared to those for proteins, there are fewer pre-trained language models available for antibody sequences. Additionally, existing pre-trained models solely rely on embedding representations using amino acids or k-mers, which do not explicitly take into account the role of secondary structure features. Here, we present a new pre-trained model called BERT2DAb. This model incorporates secondary structure information based on self-attention to learn representations of antibody sequences. Our model achieves state-of-the-art performance on three downstream tasks, including two antigen-antibody binding classification tasks (precision: 85.15%/94.86%; recall:87.41%/86.15%) and one antigen-antibody complex mutation binding free energy prediction task (Pearson correlation coefficient: 0.77). Moreover, we propose a novel method to analyze the relationship between attention weights and contact states of pairs of subsequences in tertiary structures. This enhances the interpretability of BERT2DAb. Overall, our model demonstrates strong potential for improving antibody screening and design through downstream applications.

Indexed as

Amino AcidsProteinsAmino Acid SequenceAntibodiesProtein Structure, SecondaryAmino AcidsAntibodiesProteinsAffinity predictionantibody screeningantibody sequencespretrained language modelsecondary structure

Identifiers

PMID38010801
PMCPMC10793684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.